Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. (IRWD) Stock Overview
Explore Ironwood Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
132.1M
P/E Ratio
-4.21
EPS (TTM)
$-0.19
ROE
0.10%
IRWD Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Ironwood Pharmaceuticals, Inc. (IRWD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 56.68, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.29.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.21 and a market capitalization of 132.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.